Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Liposarcoma × plitidepsin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Liposarcoma 1 Leukemia 1

Interventions

Trabectedin 2 Doxorubicin 2 sodium thiosulfate 1 plitidepsin 1 milademetan 1 avelumab 1 atezolizumab 1 X-Rays 1 TTI-621 1 Specimen Handling 1 Reverse Transcriptase Polymerase Chain Reaction 1 Platinum 1 Nelfinavir 1 Magnetic Resonance Spectroscopy 1 Immunoenzyme Techniques 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gene Expression Profiling 1 Cytoreduction Surgical Procedures 1 Cyproheptadine 1 Cisplatin 1 Blotting, Western 1 Biopsy 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01876043 2021-01-25

APLIPO

Institut Bergonié

Phase 2 Terminated

24 enrolled 10 charts

Liposarcoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡